跳至主要内容
临床试验/ISRCTN50312145
ISRCTN50312145已完成未知

A multicentre Prospective Randomised Controlled Trial of Thrombosis Prophylaxis with Warfarin in Cancer Patients with Central Venous Catheters (CVCs)

Cancer Research UK (UK)0 个研究点目标入组 1,400 人开始时间: 2004年4月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
1,400

研究概览

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Histologically or clinically confirmed diagnosis of cancer
  • 2. Patients who are due to have a CVC inserted for administration of chemotherapy
  • 3. Aged at least 16
  • 4. Adequate haematological, hepatic and renal function
  • 5. Able to provide written informed consent

排除标准

  • 1. Patients with contraindication to warfarin (including congenital bleeding disorders, anatomic lesions that bleed e.g. duodenal ulcers and profound concomitant therapy interaction)
  • 2. Patients currently on warfarin
  • 3. Patients who have previously been entered into WARP
  • 4. Use of CVC for additional purposes with the exception of antibiotic therapy and blood products
  • 5. Pregnant or lactating women
  • 6. Fertile persons, not taking adequate contraceptive measures

研究者

相似试验